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Summary
 
CD4
 
1
 
 and CD8
 
1
 
 T cells exhibit important differences in their major effector functions. CD8
 
1
 
T cells provide protection against pathogens through cytolytic activity, whereas CD4
 
1
 
 T cells
exert important regulatory activity through production of cytokines. However, both lineages
can produce interferon (IFN)-
 
g
 
, which can contribute to protective immunity. Here we show
that CD4
 
1
 
 and CD8
 
1
 
 T cells differ in their regulation of IFN-
 
g
 
 production. Both lineages re-
quire signal transducer and activator of transcription (Stat)4 activation for IFN-
 
g
 
 induced by
interleukin (IL)-12/IL-18 signaling, but only CD4
 
1
 
 T cells require Stat4 for IFN-
 
g
 
 induction
via the TCR pathway. In response to antigen, CD8
 
1
 
 T cells can produce IFN-
 
g
 
 indepen-
dently of IL-12, whereas CD4
 
1
 
 T cells require IL-12 and Stat4 activation. Thus, there is a lin-
eage-specific requirement for Stat4 activation in antigen-induced IFN-
 
g
 
 production based on
differences in TCR signaling between CD4
 
1
 
 and CD8
 
1
 
 T cells.
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I
 
nterferon (IFN)-
 
g
 
 enhances defense against bacterial and vi-
ral pathogens (1) and is produced by both innate and adap-
tive immune cells, including NK cells, CD8
 
1
 
 T cells, and
CD4
 
1
 
 T cells. NK cells are an important source of IFN-
 
g
 
 in
early infection, and can secrete IFN-
 
g
 
 upon initial activation
(2). In contrast, CD4
 
1
 
 cells produce little IFN-
 
g
 
 on primary
activation and require cytokine-dependent differentiation to
acquire this capacity (3, 4). Further, CD4
 
1
 
 T cells exhibit a
developmental dichotomy diverging to either an IFN-
 
g
 
–pro-
ducing (Th1) or IL-4–producing (Th2) phenotype (5, 6). A
similar paradigm was recently extended to CD8
 
1
 
 T cells,
where Tc1 and Tc2 subsets develop in response to conditions
that induce Th1 and Th2 subsets (7–10). However, unlike
Th2 cells, Tc2 cells retain the capacity for IFN-
 
g
 
 production,
although reduced compared with Tc1 cells, and produce
quantitatively less IL-4 relative to their CD4 counterpart (7).
For CD4
 
1
 
 T cells, Th1/Th2 polarization involves IL-12
and IL-4 signaling via the JAK-STAT Janus kinases/signal
transducer and activator of transcription) pathway (11–15).
The role of IL-12 in Th1 development was established us-
ing both IL-12– and Stat4-deficient mice (12, 13, 16). IL-
12 p40-deficient mice had impaired NK responses and
lower IFN-
 
g
 
 production from CD4
 
1
 
 T cells (16), but IFN-
 
g
 
secretion by LAK cells and generation of allo-specific CTL
were unimpeded. These studies suggested IL-12–indepen-
dent pathways in NK cells and CTLs. Stat4-deficient mice
exhibit reduced but not absent IFN-
 
g
 
 production (12, 13),
but the source was not apparent, since these studies used un-
separated splenocytes and polyclonal activation. In sum,
these studies suggest not all cell types are entirely IL-12 and
Stat4 dependent for IFN-
 
g
 
 production.
The TCR pathway has been considered the only physi-
ologic stimuli for IFN-
 
g
 
 induction in CD4
 
1
 
 T cells. How-
ever, IL-12 and IL-18 were shown to induce IFN-
 
g
 
 pro-
duction in Th1 cells by a TCR-independent mechanism
(17). The pathways activated by TCR and IL-12/IL-18
treatment are differentially sensitive to Cyclosporin A inhi-
bition and appear to induce IFN-
 
g
 
 transcription through
activation of distinct sets of factors (18). Thus the require-
ments for Stat4 and IL-12 in IFN-
 
g
 
 production may de-
pend on the activating stimulus as well as the cell type.
In this study, we directly compared the CD4
 
1
 
 and CD8
 
1
 
T cells for IL-12 and Stat4 requirements in IFN-
 
g
 
 induc-
tion through the TCR or IL-12/IL-18 pathways. We find
that CD4
 
1
 
 and CD8
 
1
 
 T cells exhibit lineage-specific dif-
ferences in requiring Stat4-activation for IFN-
 
g
 
 produc-
tion. Specifically, both CD4
 
1
 
 and CD8
 
1
 
 T cells require
Stat4 in IL-12/IL-18 induction of IFN-
 
g
 
, but only CD4
 
1
 
T cells require Stat4 for TCR induced IFN-
 
g
 
 production.
 
Materials and Methods
 
Animals.
 
Stat4-deficient DO11.10 TCR-transgenic mice have
been described previously (12, 19). 2C TCR transgenic mice (20)
were obtained from Dr. T. Hansen (Washington University, St.
Louis, MO). 
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Cytokines, Antibodies, and Other Reagents.
 
Recombinant hu-
man IL-2, IL-4, IL-12, and KJ1-26 (21) were used as previously
described (19). Recombinant murine IL-18 (Research Diagnostics
Inc.) was used at 50 ng/ml. Anti–IL-12 (TOSH) (22) and anti–
IFN-
 
g
 
 (H22) (from Dr. R.D. Schreiber, Washington University,
St. Louis, MO) were used at 10 
 
m
 
g/ml. Anti-CD3 (2C11) (from
Dr. A. Shaw, Washington University, St. Louis, MO) was coated
at 10 
 
m
 
g/ml for primary stimulations and 1 
 
m
 
g/ml for secondary
stimulation, and anti-CD28 (PV1) (from Dr. Carl June, Naval
Medical Research Institute, Bethesda, MD) was used at 1 
 
m
 
g/ml.
All other staining reagents were purchased from PharMingen.
 
T Cell Purification and Cultures.
 
Sorted CD4
 
1
 
 DO11.10 T cells
(2 
 
3 
 
10
 
5
 
/ml) were activated with 0.3 
 
m
 
M OVA peptide (OVA),
IL-2, IL-12, and irradiated BALB/c splenocytes as previously de-
scribed (3). In other experiments, DO11.10 splenocytes (3 
 
3
 
10
 
6
 
/ml) were activated with OVA, IL-2, IL-12 (Th1), or IL-4
(Th2) as indicated in the figure legends. CD8
 
1
 
 T cells were sorted
from spleen and lymph node cells of 2C mice and activated (2 
 
3
 
10
 
5
 
/ml) using irradiated BALB/c splenocytes (1.5 
 
3 
 
10
 
6
 
/ml).
CD4
 
1
 
 and CD8
 
1
 
 T cells were sorted from spleen and lymph
node cells of Stat4-deficient or wild-type mice, and stimulated
(4 
 
3 
 
10
 
5
 
/ml) with irradiated C57BL/6 splenocytes (4 
 
3 
 
10
 
6
 
/ml),
IL-2, and the indicated cytokines and antibodies.
 
ELISA and Intracellular Cytokine Staining.
 
IFN-
 
g
 
 was mea-
sured by ELISA as previously described (3). Intracellular cytokine
staining was performed as described elsewhere (18, 23). T cells
were stimulated overnight with OVA and either irradiated APCs
or plate-bound anti-CD3, and Brefeldin A (10 
 
m
 
g/ml; Epicenter
Technologies) was added for the final 4 h. Cells were harvested,
washed, and stained for CD4, CD8, and KJ1-26 as indicated in
the figure legends. After washing, cells were fixed, washed, per-
meabilized, and stained for IFN-
 
g
 
.
 
Results
 
CD4
 
1
 
 and CD8
 
1
 
 T Cells Have Distinct Requirements for
IL-12 and Stat4 in the Production of IFN-
 
g
 
.
 
Previous anal-
yses of Stat4-deficient mice reported five- to sixfold reduced
IFN-
 
g
 
 production based in part on polyclonal cellular acti-
vation of unseparated splenocytes (12, 13). To examine the
requirement for Stat4 in antigen-specific CD4
 
1
 
 T cells, we
used DO11.10 TCR-transgenic mice crossed to either wild-
type or Stat4-deficient backgrounds. Splenocytes from un-
immunized mice were primed in vitro and induced toward
Th1 and Th2 phenotypes (4) (Fig. 1 A). As expected, wild-
type DO11.10 T cells primed in the presence of IL-12
generated high levels of IFN-
 
g
 
 upon secondary stimula-
tion. In contrast, Stat4-deficient DO11.10 T cells primed
with IL-12 generated nearly 100-fold less IFN-
 
g
 
, confirm-
ing that Stat4 has a significant role in CD4
 
1
 
 T cells for
IFN-
 
g
 
 production.
After in vitro priming, clonotype-positive (KJ1-26
 
1
 
) T
cells from wild type DO11.10 transgenic mice are predomi-
nantly CD4
 
1
 
. However, in Stat4-deficient mice, as much as
25% of the KJ1-26
 
1
 
 T cells are CD4
 
2
 
 (Fig. 1 B) and CD8
 
2
 
(not shown) after in vitro priming. Double-negative T cells
have been reported to exhibit differences in Th1/Th2 regu-
lation, with impaired Th2 development (24, 25). Thus, we
wished to assess production of IFN-
 
g
 
 in CD4
 
1
 
 and CD4
 
2 
 
T
cells using intracellular cytokine staining (Fig. 1 B). Wild-
type DO11.10 T cells produced abundant intracellular IFN-
 
g
 
production, whereas Stat4-deficient DO11.10 T cells showed
a significantly lower percentage of IFN-
 
g
 
–producing cells
with lower mean fluorescence intensities relative to wild-
type T cells (Fig. 1 B). Of the Stat4-deficient DO11.10 T
cells, 6% of CD4
 
1
 
 cells produced IFN-
 
g
 
, whereas 13% of
CD4
 
2
 
 negative cells produced IFN-
 
g
 
, implying that in KJ1-
26
 
1
 
 T cells, CD4
 
1
 
 cells are more Stat4 dependent for IFN-
 
g
 
production than are CD4
 
2
 
 cells.
Figure 1. CD41 T cells exhibit strict requirement for IL-12 and Stat4 in
antigen-induced IFN-g production. (A) Splenocytes from DO11.10 or
DO11.10  3 Stat4-deficient (Stat42/2) were cultured with IL-2 and OVA,
and either IL-12 (Th1) or IL-4 (Th2) as indicated for 7 d. Cells were re-
stimulated with irradiated BALB/c splenocytes and OVA for 40 h and su-
pernatants were assayed for IFN-g. Data shown are the mean 6 SD of four
replicate determinations and is representative of three similar experiments.
(B) Cells were treated as above except Brefeldin A was added for the final 4 h
of a 19-h restimulation. Samples were stained with FITC-conjugated anti-
CD4 and biotin-conjugated KJ1-26 followed by cychrome-streptavidin
and PE-conjugated anti–IFN-g as described in Materials and Methods.
Analysis gates were set on live KJ1-261 cells. Quadrants are based on iso-
type control staining. (C) Sorted DO11.10 CD41 T cells were stimulated
with OVA/APCs, IL-2, and either IL-12 (black bars) or anti–IL-12 (gray
bars). Sorted CD81 T cells from 2C mice were stimulated with APCs, and
either IL-12 (black bars) or anti–IL-12 (gray bars). After 6 d, equal numbers
of DO11.10 and 2C T cells were reactivated in the absence of cytokines for
40 h and IFN-g was measured. Data are the mean 6 SD of IFN-g produc-
tion represented as a percentage of the IL-12–treated condition (% maxi-
mum) from four independent experiments.1357 Carter and Murphy Brief Definitive Report
These and other results suggest that IFN-g production
may be regulated differently in various T cell lineages (16,
26, and Carter, L.L., unpublished observations). Therefore,
we wished to compare CD41 and CD81 T cells from TCR-
transgenic mice for their dependence on IL-12 for driving
IFN-g production (Fig. 1 C). CD81 or CD41 T cells were
sorted from 2C TCR-transgenic mice or DO11.10 mice,
respectively, and primed with antigen in the presence of
IL-12 or anti–IL-12 antibody for 6 d, restimulated, and as-
sessed for IFN-g production. CD41 DO11.10 T cells pro-
duced high IFN-g when primed with IL-12, but virtually
undetectable IFN-g when primed with anti–IL-12 anti-
body (Fig. 1 C). In contrast, 2C CD81 T cells produced
high levels of IFN-g even when primed in the presence of
anti–IL-12 antibody, with IFN-g production being re-
duced only twofold relative to cells primed with IL-12.
Thus, CD81 T cells show significant IL-12–independent
IFN-g production, whereas CD41 T cells do not.
In the mouse, Stat4 is uniquely activated by IL-12 (11,
27, 28). Therefore, IL-12–independent IFN-g production
by CD81 T cells suggests either that Stat4 activation is IL-12
independent or that IFN-g production is Stat4 indepen-
dent. To distinguish these possibilities, we analyzed puri-
fied CD41 and CD81 T cells from Stat4-deficient and
wild-type BALB/c mice. T cells were primed in the pres-
ence of IL-12 with either allogeneic stimulators or plate-
bound anti-CD3 and anti-CD28 (Fig. 2). When primed
and reactivated with allogeneic stimulators (Fig. 2, left),
Stat4-deficient CD41 T cells produced very little IFN-g.
In comparison, Stat4-deficient CD81 T cells produced sig-
nificantly more IFN-g, although the level observed was re-
duced three- to fourfold relative to the wild-type CD81
control. When T cells were reactivated with anti-CD3
(Fig. 2, middle), Stat4-deficient CD41 T cells remained
poor IFN-g producers, whereas Stat4-deficient CD81 T
cells produced IFN-g at levels similar to wild-type CD81
controls (Fig. 2, middle). When T cells were primed with
anti-CD3/anti-CD28 and IL-12, and reactivated with anti-
CD3, Stat4-deficient CD41 T cells again produced very
low levels of IFN-g, whereas Stat4-deficient CD81 T cells
produced high levels of IFN-g (Fig. 2, right).
We extended these results with intracellular cytokine
staining (Fig. 3). Purified CD41 and CD81 T cells from
Stat4-deficient and wild-type mice were primed in the
presence of IL-12 using either APCs or anti-CD3/anti-
CD28, and reactivated with APCs (Fig. 3 A) or anti-CD3
(Fig. 3 B). CD41 T cells again showed a strict requirement
for Stat4 in IFN-g production with both forms of activa-
tion. In contrast, Stat4-deficient CD81 T cells produced
abundant IFN-g with either form of activation. With anti-
CD3 treatment, equivalent percentages of Stat4-deficient
and wild-type CD81 T cells produced IFN-g, whereas
with activation by APCs, IFN-g1 Stat4-deficient CD81 T
Figure 2. CD81 T cells exhibit Stat4-independent IFN-g production.
CD41 (black bars) and CD81 (gray bars) T cells were sort-purified from
pooled lymph nodes and spleens of wild-type or Stat4-deficient (Stat4 2/2)
mice and stimulated with IL-2, IL-12, and irradiated allogeneic spleno-
cytes (H-2b) (left and middle) or plate-bound anti-CD3 and anti-CD28
(right). After 6 d, cells were harvested and reactivated at 4 3 105/ml with
irradiated allogeneic APCs (left) or plate-bound anti-CD3 (middle and
right), and IFN-g was measured after 40 h. Data in left and middle panels
are the mean 6 SD pooled from six independent experiments. Data in
right panel are the mean 6 SD from one of two experiments.
Figure 3. CD41 and CD81 T cells have distinct requirements for Stat4
in TCR-induced IFN-g production. CD41 and CD81 T cells were sorted
from lymph nodes and spleens of wild-type or Stat4-deficient mice and
stimulated in the presence of IL-2 and IL-12 with either irradiated alloge-
neic splenocytes (A) or plate-bound anti-CD3 and anti-CD28 (B). After
5 d, cells were restimulated with irradiated allogeneic APCs (A) or plate-
bound anti-CD3 (B) for 17 h with Brefeldin A added for the final 5 h.
Samples were stained with FITC-conjugated anti-CD4 or anti-CD8, fixed,
permeabilized, and stained with PE-conjugated anti–IFN-g. Syngeneic
splenocytes were used as stimulators for a specificity control and no IFN-g1
cells were detected (data not shown). Gates for analysis excluded dead cells
and quadrants were set based on isotype control staining. The percentages
displayed indicate the frequency of cells positive for IFN-g in the CD41
(top) or CD81 (bottom) population, rather than the percentage of total
cells. Data shown are representative of three independent experiments.1358 Lineage-specific Stat4 Requirement in IFN-g Production
cells were reduced twofold. Thus, in contrast to CD41 T
cells, CD81 T cells show significant Stat4-independent
IFN-g production, which is most apparent with direct
TCR-mediated cellular activation.
Since APCs can produce IL-12 and IL-18 (4, 29, 30), T
cell activation using APCs could engage both the TCR and
the IL-12/IL-18 pathway for IFN-g production. There-
fore, we asked if these pathways were differentially Stat4
dependent in CD41 and CD81 T cells (Fig. 4). Purified
CD41 and CD81 T cells from Stat4-deficient and wild-
type mice were primed with IL-12 and allogeneic APCs
and reactivated on day 6 with either anti-CD3 or IL-12/
IL-18. In response to anti-CD3, wild-type CD41, but not
Stat4-deficient CD41, T cells produced IFN-g. As above,
both wild-type and Stat4-deficient CD81 T cells produced
IFN-g. However, in response to IL-12/IL-18 treatment,
both CD41 and CD81 Stat4-deficient T cells failed to pro-
duce IFN-g. Thus, the IL-12/IL-18 pathway for IFN-g
production is strictly Stat4 dependent in both CD41 and
CD81 T cells. In contrast, the TCR-induced pathway for
IFN-g production is Stat4 dependent only in CD41, and
not CD81, T cells.
Discussion
Previous observations have suggested the existence of
both IL-12–dependent and –independent pathways for
IFN-g production (12, 13, 16, 31–33). However, since
few of these studies analyzed purified cell types, the effects
of Stat4 in specific lineages were potentially obscured. Fur-
thermore, recent studies have demonstrated that IFN-g gene
transcription can be activated by two distinct signaling path-
ways, one by TCR signaling and other by IL-12 and IL-18
(18), and these pathways were not individually examined in
the previous studies. Therefore, the aim of this study was to
analyze differences between CD41 and CD81 T cells in their
regulation of these two pathways for IFN-g production.
In this paper, we make several new observations. First,
we show that the IL-12/IL-18 pathway for induction of
IFN-g operates in CD81 as well as CD41 T cells. Second,
we formally demonstrate that the IL-12/IL-18 pathway
is strictly Stat4 dependent in both CD41 and CD81 T
cells. Third, we have identified an unexpected difference
between CD41 and CD81 T cells in TCR signaling. Spe-
cifically, CD41 T cells produce IFN-g in a completely
Stat4-dependent manner, whereas CD81 T cells are Stat4
independent for TCR-induced IFN-g production.
Common Regulation in CD41 and CD81 T Cells for IL-12/
IL-18–induced IFN-g. Two pathways are now recognized
for IFN-g induction (17, 18), one via TCR-signaling and
another through IL-12 and IL-18 that acts independently
of antigen stimulation (17). The TCR- and IL-12/IL-18–
induced pathways were shown to be pharmacologically dis-
tinct and to induce different transcription factors (18). In this
study, we show that IL-12/IL-18 induction of IFN-g oper-
ates in CD81 as well as CD41 T cells (Fig. 4). The existence
of antigen-independent IFN-g production by previously ac-
tivated T cells from both CD4 and CD8 lineage has signifi-
cant implications for immune regulation. By stimulating
production of cytokines in an antigen-independent manner,
this pathway allows antigen-specific T cells to operate like
innate immune cells. The Stat4-dependence of the IL-12/
IL-18–induced pathway in both CD41 and CD81 lineages
suggest a common IFN-g regulatory mechanism.
Distinct Regulation in CD41 and CD81 T Cells for
TCR-induced IFN-g Production. In contrast to IL-12/IL-18–
induced IFN-g, TCR-induced signaling revealed a striking
difference in the requirement for Stat4 between CD41 and
CD81 T cells. Unseparated Stat4-deficient splenocytes dis-
played a partial reduction in IFN-g production in previous
studies (12, 13), whereas pure populations of CD41 T cells
show a much more stringent requirement for Stat4 (Fig. 1 A).
In contrast, Stat4-deficient CD81 T cells generated abun-
dant IFN-g particularly when activated through the TCR.
When CD81 T cells were activated using APCs, a partial
loss of IFN-g production was observed in Stat4-deficient
CD81 T cells relative to wild-type controls (Figs. 2, left,
and 3 A), suggesting that activation with APCs engages
both TCR (Stat4-independent) and IL-12/IL-18 (Stat4-
dependent) pathways. Activation of CD81 T cells using
anti-CD3 restricts activation to the TCR (Stat4-indepen-
dent) pathway, resulting in equivalent levels of IFN-g pro-
duction by Stat4-deficient and wild-type CD81 T cells.
Distinct regulation of IFN-g gene activation between
CD41 and CD81 T cells has previously been suggested
(26). A Stat4-independent mechanism for IFN-g produc-
tion development has recently been described (34), but as it
operated only in the absence of Stat6 and in CD41 T cells,
it is distinct from the pathway described here.
Differences in TCR signaling between CD41 and CD81
lineages could reside at several levels. First, CD41 and
CD81 T cells may differ in expression of signaling compo-
nents downstream of the TCR. For example, certain mito-
gen-activated protein (MAP) kinases implicated in IFN-g
induction (35, 36) could be differentially expressed or acti-
vated in CD41 versus CD81 T cells, being Stat4 dependent
only in CD41 T cells. Second, chromatin accessibility of
the IFN-g gene may differ between primary CD41 and
CD81 lineages. In this model, the IFN-g gene would be
accessible to TCR-induced factors independently of Stat4
in CD81 T cells, but not in CD41 T cells. However, IFN-g
Figure 4. CD81 T cells pos-
sess both Stat4-independent
(TCR) and Stat4-dependent (IL-
12/IL-18) pathways for IFN-g
induction.  CD41 (top) and
CD81 (bottom) T cells were
sorted from lymph nodes and
spleens of wild-type (black bars)
or Stat4-deficient (gray bars)
mice and stimulated with irradi-
ated allogeneic splenocytes, IL-2,
and IL-12. After 5 d, cells were
harvested and equal cell numbers
were restimulated by the addi-
tion of IL-12 and IL-18 or plate-
bound anti-CD3 for 40 h, and IFN-g was measured by ELISA. Data are
the mean 6 SD of four independent experiments.1359 Carter and Murphy Brief Definitive Report
chromatin structure in CD41 versus CD81 T cells has not
yet been compared. Finally, coreceptor signaling could ac-
count for the present observations. CD8 may provide a sig-
nal that bypasses a Stat4 requirement in IFN-g production,
or conversely CD4 may provide a signal imposing such a re-
quirement. Indeed, differences between coreceptor associa-
tion with src family kinase Lck have been reported (37–40),
and lack of CD4 expression impairs Th2 responses (24, 25).
In summary, the study presented here makes the first dis-
tinction between CD41 and CD81 T cells for the role of
Stat4 in regulation of IFN-g expression. Given the impor-
tance of IFN-g in responses to pathogens and in autoim-
mune processes, it will be important to determine the basis
of these lineage-specific differences in the Stat4-require-
ment for IFN-g gene regulation.
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